MedTrace Logo

The Effect of Emotional Freedom Technique on Premenstrual Syndrome

NCT05499000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2024-04-01

No results posted yet for this study

Summary

Objective: This study was conducted to evaluate the Effect of Emotional Freedom Technique on Premenstrual Syndrome.

Methodology: The research will be conducted as a randomized controlled trial. The research will be carried out with students studying at the Department of Midwifery, Faculty of Health Sciences, İnönü University, between September and October 2022. The sample size of the study was calculated as 102 people with an effect size of 0.80 and a power of 0.95. Premenstrual syndrome scale will be applied to all students participating in the research first and those who score 110 and above will be listed. Experimental and control groups will be determined by randomization. Personal information form, subjective experience unit scale and premenstrual syndrome scale will be used to collect data.

SPSS 22.0 package program will be used in the evaluation of the data. The independent variable of the research is the emotional liberation technique. The dependent variable of the study is the mean scores of the participants from the subjective experience unit scale and premenstrual syndrome scale.

Conditions

  • Premenstrual Syndrome
  • Emotional Problem

Interventions

BEHAVIORAL

Emotional freedom technique

Emotional freedom technique will be applied online with the researcher in 2 sessions, 3 days apart. KBF, SUE, PMSS tests will be applied before the intervention, SUE will be applied before and after each session, At the end of the 2nd session, post-test data will be taken with SUE, PMSS.

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Principal Investigators

  • Zeliha OZSAHİN, PhD · https://www.inonu.edu.tr/akademik/zeliha.ozsahin

  • Yeşim AKSOY DERYA, PhD · https://www.inonu.edu.tr/akademik/yesim.aksoy

  • Çiğdem KARAKAYALI AY, PhD · https://saglikbilimleri.ozal.edu.tr/?page_id=7732

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-09-01
Completion
2023-09-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05499000 on ClinicalTrials.gov